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BACKGROUND: Intrauterine insemination (IUI) can be performed with or without controlled ovarian hyper-
stimulation (COH). Studies in which the additional benefit of COH on IUI for cervical factor subfertility is assessed
are lacking. We assessed whether COH in IUI improved pregnancy rates in cervical factor subfertility.
METHODS: We performed a historical cohort study among couples with cervical factor subfertility, treated with
IUI. A cervical factor was diagnosed by a well-timed, non-progressive post-coital test with normal semen
parameters. We compared ongoing pregnancy rate per cycle in groups treated with IUI with or without COH. We
tabulated ongoing pregnancy rates per cycle number and compared the effectiveness of COH by stratified univari-
able analysis. RESULTS: We included 181 couples who underwent 330 cycles without COH and 417 cycles with
COH. Ongoing pregnancy rates in IUI cycles without and with COH were 9.7% and 12.7%, respectively (odds
ratio 1.4; 95% confidence interval 0.85–2.2). The pregnancy rates in IUI without COH in cycles 1, 2, 3 and 4 were
14%, 11%, 6% and 15%, respectively. For IUI with COH, these rates were 17%, 15%, 14% and 16%, respect-
ively. CONCLUSIONS: Although our data indicate that COH improves the pregnancy rate over IUI without
COH, IUI without COH generates acceptable pregnancy rates in couples with cervical factor subfertility. Since
IUI without COH bears no increased risk for multiple pregnancy, this treatment should be seriously considered in
couples with cervical factor subfertility.
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Introduction
Intrauterine insemination (IUI) is a common treatment in
subfertile couples. Intrauterine insemination can be per-
formed with or without controlled ovarian hyperstimulation
(COH). COH carries the risk of ovarian hyperstimulation
syndrome and multiple pregnancy (Levene et al., 1992).
Moreover, IUI with COH is both a burden to the patient and
costly due to the use of gonadotrophins and the need for
monitoring of follicular development and growth. In view of
these drawbacks, IUI without COH would be preferable over
IUI with COH if the pregnancy rate for IUI without COH
was more or less comparable.
The effectiveness of IUI is well established in couples in
whom subfertility is due to a male factor or when subfertility
is unexplained (Hughes, 1997; Cohlen et al., 2000). In male
factor subfertility, IUI without COH has been proven to be
equally as effective as IUI with COH, and should therefore
be the first choice of treatment (Cohlen et al., 2000). In the
treatment of unexplained subfertility, IUI with COH doubles
pregnancy rates compared with IUI without COH (Guzick
et al., 1994, 1999).
In contrast to the former two indications, data on the effec-
tiveness of IUI in cervical factor subfertility are conflicting.
Five randomized studies have reported on the effectiveness
of IUI compared with timed intercourse in couples with cer-
vical factor subfertility. Three of these studies clearly indi-
cated a beneficial effect of IUI (te Velde et al., 1989; Kirby
et al., 1991; Check and Spirito, 1995), whereas two others
did not report such an effect (Glazener et al., 1987; Friedman
et al., 1989). In all of these studies, IUI was performed with-
out COH. Studies, randomized or non-randomized, in which
the additional benefit of COH on IUI for cervical factor sub-
fertility is assessed are lacking.
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The aim of this study was therefore to assess whether
controlled ovarian hyperstimulation in IUI is of additional
benefit in cervical factor subfertility.
Materials and methods
Patients
We performed a historical cohort study among consecutive couples
with cervical factor subfertility who had been treated with IUI. The
data had been collected between 1986 and 2002 in the Onze Lieve
Vrouwe Gasthuis and the Vrije Universiteit Medical Centre, both
located in Amsterdam, The Netherlands.
All couples had been trying to conceive for at least 12 months,
and all had undergone a fertility work-up consisting of a medical
history, confirmation of an ovulatory cycle either by basal body temp-
erature, ultrasound and/or mid-luteal serum progesterone, semen
analysis and a post-coital test. Tubal patency of both tubes and
absence of endometriosis or uterine anomalies were confirmed by
hysterosalpingography and/or laparoscopy.
All women diagnosed with cervical factor subfertility who had
started IUI were included in the study. Cervical factor was diag-
nosed by means of a well-timed, non-progressive post-coital test,
and was defined as the absence of at least one progressive motile
spermatozoon in good cervical mucus at a magnification of 400£ ,
despite normal semen parameters. The timing was performed with
transvaginal sonography, and usually the post-coital was repeated in
a second cycle. Intercourse would have taken place between 6 and
18 h prior to the test. Since a cervical factor can only be diagnosed
in the presence of normal semen, the diagnoses of male and cervical
factor were mutually exclusive.
For each couple, we registered female age, duration of subferti-
lity, whether subfertility was primary or secondary, number of fol-
licles and cycle number. Furthermore, we registered whether the IUI
was performed with or without COH.
IUI protocol
The choice for IUI with or without COH was based on local proto-
cols in the participating centres. If IUI was performed without COH,
ovulation detection was performed with urine LH tests (a semi-
quantitative monoclonal antibody-based kit; OvuQuick; Quid, San
Diego, CA, USA) with a detection level of 40 IU, or by transvaginal
sonography. Patients tested their urine samples once or twice a day,
starting on an individually calculated cycle day. Patients were inse-
minated 20–30 h after the endogenous LH surge had been detected
in the urine sample. In cases where follicular growth was monitored
by transvaginal sonography, HCG (Pregnyl; Organon, Oss, The
Netherlands) was administered when the dominant follicle had a
diameter of at least 16 mm. Semen was inseminated 36–40 h there-
after. A maximum of 0.3 ml suspension of processed spermatozoa
was introduced into the uterine cavity with a catheter 10 cm in
length (International Medical, Zutphen, The Netherlands).
COH was performed with clomiphene citrate or FSH to achieve
the growth of two or three dominant follicles. In cases where hyper-
stimulation was performed with FSH, baseline transvaginal sono-
graphy was carried out at cycle day 3 to exclude ovarian cysts
.20 mm. Thereafter, patients injected themselves subcutaneously
with 1 ampoule (75 IU) of FSH, Gonal F (Serono Benelux BV, Den
Haag, The Netherlands) or Puregon (Organon), daily until trans-
vaginal sonography showed at least one follicle with a diameter of
16 mm. In the event of such a follicle, 5000 IU HCG (Pregnyl;
Organon) was given and patients were inseminated 36 h later. If
hyperstimulation was performed with anti-estrogenic tablets, the
patient took 100 mg clomiphene citrate on cycle day 5 for 5 days.
On cycle day 10 the first transvaginal sonography was performed.
When at least one follicle with a diameter of 16 mm was seen,
5000 IU HCG was given subcutaneously, and the patients were inse-
minated 36 h later.
The administration of HCG was withheld and IUI was not carried
out in both stimulation protocols when more than three follicles
with a diameter of at least 16 mm, or more than four follicles with a
diameter of at least 14 mm, were present.
Semen preparation
In general, semen samples were produced and prepared ,2 h prior
to insemination. The semen was processed using a density gradient
centrifugation (15 min at 750 g) and a washing step (7 min at 300 g)
with 2 ml culture medium containing 1% HAS (CLB, Amsterdam,
The Netherlands). Less than 15 min before insemination the sperma-
tozoa suspension was centrifuged (7 min at 200 g) and the cell pellet
resuspended in 200–250ml culture medium.
Data analysis
The analysis was performed at cycle level, i.e. each cycle was con-
sidered as a separate unit of analysis. We used ongoing pregnancy
as the end-point of the study. Ongoing pregnancy was defined as the
presence of fetal cardiac activity at transvaginal sonography at a
gestational age of at least 12 weeks. We compared the distribution
of the baseline characteristics over the two treatment groups using a
x2-test or a Wilcoxon test where appropriate. For each group, we
calculated ongoing pregnancy rates per cycle. The treatment effect
was expressed as an odds ratio (OR) with 95% confidence interval
(CI).
The outcome of IUI is dependent on various prognostic character-
istics of the couple (Steures and van der Steeg, 2004). An unequal
distribution of such characteristics might influence the results and
conclusion of this study. To control for the bias generated by poten-
tial confounders, we performed a multivariate logistic regression
analysis, in which we calculated ORs and 95% CIs. Baseline charac-
teristics included in this analysis were female age, duration of the
subfertility, whether subfertility was primary or secondary and cycle
number. As follicle growth is an effect of the use of COH, we felt
that correction of this baseline characteristic was not appropriate.
Because multiple cycles from the same patient were included, the
data analysed were interrelated. Therefore, ORs and 95% CIs were
corrected by taking into account the clustering of data (Huber,
1967). Data were collected over a period of .15 years in two ferti-
lity centres in The Netherlands. Thus, changes in IUI practice over
time, as well as practice differences between the two locations,
might have affected the results. Therefore, we performed a multi-
variate analysis in which we controlled for differences over time
and between centres to control for these potential biases. To assess
whether the treatment effect after COH was dependent on the num-
ber of follicles, we tabulated the ongoing pregnancy rate per cycle
as a function of the number of follicles.
Subsequently, we simulated the ongoing pregnancy rate per
couples for four cycles of treatment. To do so, we used the ongoing
pregnancy rate per cycle for IUI with and without COH obtained
from the univariable analysis.
Results
Overall, 181 couples were included who underwent 747
cycles. There were 330 IUI cycles without COH (44%) and
417 cycles with COH (56%). Of the 417 stimulated cycles,
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298 were stimulated with clomiphene citrate (71%) and 119
were stimulated with FSH (29%).
The baseline characteristics of the IUI cycles in each
group, except for whether subfertility was primary or second-
ary, were not equally distributed between the two groups
(Table I). In the IUI group without COH the mean female
age was higher, the mean duration of subfertility was lower
and more inseminations were performed in cycles 1–3. Data
on multifollicular growth were not registered in 27% of
cycles. Of the registered cycles, multifollicular growth was
achieved in 53% of the IUI cycles with COH (113/213), as
compared with the 2% of the IUI cycles without COH
(7/330) (Table I).
The total pregnancy rates in IUI without and with COH
were 11% (36/330) and 14% per cycle (60/417), respectively.
The miscarriage rates in IUI without and with COH were
1.2% (4/330) and 1.7% per cycle (7/417), respectively. The
ongoing pregnancy rates in IUI without and with COH were
9.8% (32/330) and 12.3% per cycle (53/417), respectively
(OR 1.4; 95% CI 0.85–2.2).
Multivariable regression analysis did slightly alter the OR
of COH on the outcome of IUI, to 1.6 (95% CI 0.99–2.6)
(Table II). This implies that the effect of COH on an ongoing
pregnancy was slightly influenced by the unequal distribution
of the baseline characteristics. In the analysis performed to
control for the potential bias over different time periods and
between the two participating centres we found no change in
the direction or magnitude of the effect of COH on IUI (data
not shown).
Table III shows the ongoing pregnancy rates in each cycle
number and the stratified univariable analysis on cycle level.
The pregnancy rates in IUI without COH in cycles 1, 2, 3
and 4 were 14%, 11%, 6% and 15%, respectively. For IUI
with COH, these rates were 17%, 15%, 14% and 16%,
respectively. In the first four cycles, ORs varied from 1.1 to
2.5, indicating an additional effect of COH on the ongoing
pregnancy rates varying from almost no effect to a 2.5 times
higher ongoing pregnancy rate. Table IV shows the impact of
the number of follicles on the ongoing pregnancy rates. Two
follicles at the time of insemination did not increase the
ongoing pregnancy rate in cervical factor subfertility com-
pared with one follicle. No conclusion could be drawn on the
effect of higher numbers of follicles because of lack of data.
Discussion
In this study, the first to report on the additional effect of
COH on IUI in couples with cervical factor subfertility, we
found a 1.6 times higher ongoing pregnancy rate after IUI
with COH compared with IUI without COH in the first four
cycles. However, pregnancy rates in IUI without hyperstimu-
lation were on average still almost 10% per cycle.
In general, four cycles of IUI were given over 6 months. If
we extrapolate the ongoing pregnancy rate per cycle obtained
in this study to a 6-month treatment strategy, the ongoing
pregnancy rate for IUI with COH would be 52%, and for IUI
without COH 32%.
Our study has several limitations. First, we analysed retros-
pective data on non-randomized patients, with an unequal
distribution of the baseline characteristics in the two
Table I. Baseline characteristics on cycle level
IUI without
hyperstimulation
(n ¼ 330)
IUI with
hyperstimulation
(n ¼ 417)
P-value
Female age (years)
[mean (range)]
34 (24–43) 34 (22–43) 0.02
Duration of subfertility
(years) [mean (range)]
3 (1–14) 4 (1–10) ,0.001
Primary subfertility (%) 251 (65) 290 (70) 0.20
Secondary subfertility (%) 115 (35) 127 (30)
Cycle number [n (%)] ,0.001
Cycle 1 100 (30) 81 (19)
Cycle 2 83 (25) 65 (16)
Cycle 3 65 (20) 57 (14)
Cycle 4 33 (10) 61 (15)
Cycle 5 20 (6) 54 (13)
Cycle $6 29 (9) 99 (23)
Number of follicles [n (%)] ,0.001
1 323 (97) 100 (24)
2 6 (3) 82 (20)
3 1 (0.5) 27 (7)
$4 0 (0) 4 (1)
Not registered 0 (0) 204 (48)
Table II. Multivariate analysis on the baseline characteristics
Unadjusted Adjusted for
confounders
OR 95% CI OR 95% CI
Without COH 1.0 1.0
With COH 1.4 0.85–2.2 1.6 0.99–2.6
Female age 0.9 0.90–1.0
Duration of subfertility 1.0 0.88–1.2
Primary subfertility 1.0
Secondary subfertility 1.2 0.73–1.9
Cycle number 0.81 0.70–0.94
Table III. Ongoing pregnancy rates in each cycle and stratified univariate
analysis
Cycle IUI without
hyperstimulation
[% (n)]
IUI with
hyperstimulation
[% (n)]
Univariate
analysis
OR 95% CI
Cycle 1 14 (14) 17 (14) 1.3 0.57–2.9
Cycle 2 11 (9) 15 (10) 1.5 0.57–3.9
Cycle 3 6 (4) 14 (8) 2.5 0.71–8.8
Cycle 4 15 (5) 16 (10) 1.1 0.34–3.5
Cycle 5 0 (0) 7 (4) 2158 0.00–1
Cycle $6 0 (0) 7 (7) 2053 0.00–1
Table IV. Percentages of cycles of IUI with COH and ongoing pregnancies
depending on number of follicles
Number of follicles IUI with COH [n (%)] Ongoing pregnancies [n (%)]
1 100 (24) 11 (11)
2 82 (20) 10 (12)
3 27 (7) 5 (18)
$4 4 (1) 2 (50)
Not registered 204 (48) 25 (12)
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treatment modalities; however, multivariate regression analy-
sis controlled for this bias and we corrected the results
accordingly. Secondly, the choice of treatment, i.e. IUI with
COH or without COH, was based on local protocols. This
might create a bias, as couples with a good prognosis might
have received IUI without COH more often than couples
with a poor prognosis. Correcting for this potential bias by
multivariate regression analysis did not change the results.
Thirdly, the pre-ovulatory follicle number was only available
for 73% of cycles, as one centre did not record this item.
Since this item was missing in all cycles regardless of the
result, pregnancy or not, data were missing at random and
therefore not subject to bias (Greenland and Finkle, 1995).
Finally, data were only entered in the local databases when
insemination was performed, thus hampering an analysis
with the number of started cycles as the denominator. Others
have reported 3% and 10% cancellation rates in IUI with and
without COH, respectively (Guzick et al., 1999). If we
take such cancellation rates into account in our analysis,
the average ongoing pregnancy rates of the started IUI cycles
without and with COH would have been 9% (32/330 þ 33
cancelled cycles) and 12% (53/417 þ 13 cancelled cycles),
respectively, which is a marginal change compared with our
findings.
In the couples treated with COH, two different stimulation
protocols were used, clomiphene citrate and FSH. Since we
found similar results when analysis was performed for sepa-
rate stimulation protocols (data not shown), we pooled these
data into one COH group in the final analysis. Moreover, in a
previous study we did not find an effect of different types of
COH protocols on ongoing pregnancy rates in IUI (Steures
and van der Steeg, 2004).
Although IUI with COH is more effective than IUI without
COH, in clinical decision-making the risks of these two treat-
ment policies should also be taken into account. In daily
practice, COH carries the risks of multiple pregnancy and
ovarian hyperstimulation syndrome. In case of multifollicular
growth, which is the primary aim of COH, patients are forced
to trade off between the risks of a multiple pregnancy and
cancellation of the IUI cycle, the latter obviously implying
no pregnancy at all. Moreover, the risk of multiple pregnan-
cies cannot always be foreseen, because in IUI with COH
these pregnancies can also arise from borderline or small
follicles in cycles that are not cancelled based on existing
guidelines. In contrast, IUI without COH bears no increased
medical risk at a lower financial cost.
In conclusion, the present study indicates that in patients
with cervical factor subfertility, IUI with COH is more effec-
tive compared with IUI without controlled ovarian hypersti-
mulation. Nevertheless, since the average ongoing pregnancy
rates were almost 10% per cycle in the first four IUI cycles
without COH, IUI without COH should be considered as a
treatment option in couples with cervical factor subfertility.
Such a policy avoids side effects from ovarian hyperstimu-
lation, i.e. multiple pregnancies and ovarian hyperstimulation
syndrome, and decreases costs. Moreover, randomized clini-
cal trials on the subject are needed to confirm this finding.
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